Lagevrio (Molnupiravir)
What is a Generic Drug?
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Coming Soon – Save up to 85%
Sign up to get exclusive coupon discounts and be the first to be notified when we have this product available.
Prescription Required
-
Product Details
Description
Lagevrio (molnupiravir) is authorized for use under an Emergency Use Authorization to treat adults with mild to moderate coronavirus disease 2019 (COVID-19).
Lagevrio comes in 200 mg oral capsules.
Directions
Take Lagevrio exactly as prescribed by your doctor. If you have any questions or concerns, talk to your doctor or pharmacist.
The dose of Lagevrio is 800 mg (or four 200 mg capsules) by mouth every 12 hours for 5 days. You may take the medication with or without food.
Ingredients
Molnupiravir is the active ingredient in Lagevrio.
Contraindications
Contraindications have not been identified, as there is limited data available.
Cautions
- Before you start taking Lagevrio, talk to your doctor about:
- All the prescription and nonprescription medications you take. There have not been any Lagevrio drug interactions identified based on the limited data that is available.
- Your allergies
- Your current health problems and past medical history
- If you are pregnant or breastfeeding
- Pregnant patients are not advised to take Lagevrio, as harm to an unborn baby may occur. Benefits must outweigh the risks before a pregnant patient is prescribed Lagevrio. If a pregnant patient is prescribed Lagevrio, the healthcare provider should document it in a pregnancy registry that monitors pregnancy outcomes in patients taking Lagevrio.
- Patients of childbearing age should be educated on the potential risk to an unborn baby and be advised to use effective birth control methods during treatment and for 4 days after taking the last dose.
- Pregnancy should be confirmed before treatment is started.
- Allergic reactions, including anaphylaxis, have occurred during Lagevrio treatment. Lagevrio should be stopped once an allergic reaction occurs.
- Lagevrio is not authorized for use in patients younger than 18 years old, as it may affect the growth of bone and cartilage. The safety and efficacy of Lagevrio has not been determined in pediatric patients.
Side Effects
Diarrhea, nausea, and dizziness are common Lagevrio side effects. Other side effects can occur. Tell your doctor right away if you have side effects that bother you or won’t go away.
You can buy Lagevrio here. Ask your doctor about Lagevrio.
Reference
Lagevrio. Rahway, NJ: Merck & Co., Inc.; 2023.
IMPORTANT NOTE: The above information is intended to increase awareness of health information and does not suggest treatment or diagnosis. This information is not a substitute for individual medical attention and should not be construed to indicate that use of the drug is safe, appropriate, or effective for you. See your health care professional for medical advice and treatment.Product Code : 14396
-
Product Reviews
